Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens
Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in h...
Gespeichert in:
Veröffentlicht in: | Biochimica et biophysica acta 2015-02, Vol.1851 (2), p.117-128 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 128 |
---|---|
container_issue | 2 |
container_start_page | 117 |
container_title | Biochimica et biophysica acta |
container_volume | 1851 |
creator | Dorninger, Fabian Brodde, Alexander Braverman, Nancy E. Moser, Ann B. Just, Wilhelm W. Forss-Petter, Sonja Brügger, Britta Berger, Johannes |
description | Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens.
•PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion. |
doi_str_mv | 10.1016/j.bbalip.2014.11.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2000333462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1388198114002443</els_id><sourcerecordid>1645773065</sourcerecordid><originalsourceid>FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</originalsourceid><addsrcrecordid>eNqFks9u1DAQxiMEoqXwBgj5yCXB4z9xckFCFbRIlbiUs-XEk41XThxi70p7QOIheEKepK62tPRCD5atmd984xl9RfEWaAUU6g_bquuMd0vFKIgKoKJUPitOoVFtyWponuc3b5oS2gZOilcxbikFybl8WZwwKWouVHta_LwME4aYTHSRhIEsY4j5ZF1nI_nz6ze5HpF43KN_SJvk7MFjGs0cvJncjCS5zZj8gRhrlhRJCqTP2Q1G4mbyiFy8iZPxYYNzfF28GIyP-ObuPiu-f_l8fX5ZXn27-Hr-6ars61qm0oKyg8FBKdvRbmAS-q4VqrOqVTzHpAJmRQ4YjpQr2UHXUzZYxmgG6MDPio9H3WXXTWh7nNNqvF5WN5n1oINx-nFmdqPehL0WnEOtRBZ4fyewhh87jElPLvbovZkx7KJmlFLOuajZkyg0jLdCSoCn0VpIlQeoZUbFEe3XEOOKw_3ngepbP-itPvpB3_pBA-jsh1z27t_B74v-GuBhM5jXv3e46tg7nHu0bsU-aRvc_zvcANvazQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1645773065</pqid></control><display><type>article</type><title>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dorninger, Fabian ; Brodde, Alexander ; Braverman, Nancy E. ; Moser, Ann B. ; Just, Wilhelm W. ; Forss-Petter, Sonja ; Brügger, Britta ; Berger, Johannes</creator><creatorcontrib>Dorninger, Fabian ; Brodde, Alexander ; Braverman, Nancy E. ; Moser, Ann B. ; Just, Wilhelm W. ; Forss-Petter, Sonja ; Brügger, Britta ; Berger, Johannes</creatorcontrib><description>Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens.
•PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion.</description><identifier>ISSN: 1388-1981</identifier><identifier>ISSN: 0006-3002</identifier><identifier>EISSN: 1879-2618</identifier><identifier>DOI: 10.1016/j.bbalip.2014.11.005</identifier><identifier>PMID: 25463479</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Acyltransferases - deficiency ; Acyltransferases - genetics ; Adaptation, Physiological ; Alzheimer disease ; Alzheimer's disease ; Animals ; Arachidonic acid ; Arachidonic Acid - metabolism ; biosynthesis ; brain ; cell membranes ; Cells, Cultured ; Chondrodysplasia Punctata, Rhizomelic - enzymology ; Chondrodysplasia Punctata, Rhizomelic - genetics ; Compensation ; Disease Models, Animal ; Docosahexaenoic acid ; Docosahexaenoic Acids - metabolism ; ethanolamine ; fibroblasts ; Fibroblasts - enzymology ; Genetic Predisposition to Disease ; Gray Matter - enzymology ; Homeostasis ; Humans ; mice ; Mice, Inbred C57BL ; Mice, Knockout ; omega-3 fatty acids ; patients ; Peroxisome ; Phenotype ; phosphatidylethanolamines ; Phosphatidylethanolamines - metabolism ; Plasmalogen ; Plasmalogens - metabolism ; Severity of Illness Index</subject><ispartof>Biochimica et biophysica acta, 2015-02, Vol.1851 (2), p.117-128</ispartof><rights>2014</rights><rights>Copyright © 2014. Published by Elsevier B.V.</rights><rights>2014 The Authors. Published by Elsevier B.V. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</citedby><cites>FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1388198114002443$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25463479$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dorninger, Fabian</creatorcontrib><creatorcontrib>Brodde, Alexander</creatorcontrib><creatorcontrib>Braverman, Nancy E.</creatorcontrib><creatorcontrib>Moser, Ann B.</creatorcontrib><creatorcontrib>Just, Wilhelm W.</creatorcontrib><creatorcontrib>Forss-Petter, Sonja</creatorcontrib><creatorcontrib>Brügger, Britta</creatorcontrib><creatorcontrib>Berger, Johannes</creatorcontrib><title>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</title><title>Biochimica et biophysica acta</title><addtitle>Biochim Biophys Acta</addtitle><description>Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens.
•PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion.</description><subject>Acyltransferases - deficiency</subject><subject>Acyltransferases - genetics</subject><subject>Adaptation, Physiological</subject><subject>Alzheimer disease</subject><subject>Alzheimer's disease</subject><subject>Animals</subject><subject>Arachidonic acid</subject><subject>Arachidonic Acid - metabolism</subject><subject>biosynthesis</subject><subject>brain</subject><subject>cell membranes</subject><subject>Cells, Cultured</subject><subject>Chondrodysplasia Punctata, Rhizomelic - enzymology</subject><subject>Chondrodysplasia Punctata, Rhizomelic - genetics</subject><subject>Compensation</subject><subject>Disease Models, Animal</subject><subject>Docosahexaenoic acid</subject><subject>Docosahexaenoic Acids - metabolism</subject><subject>ethanolamine</subject><subject>fibroblasts</subject><subject>Fibroblasts - enzymology</subject><subject>Genetic Predisposition to Disease</subject><subject>Gray Matter - enzymology</subject><subject>Homeostasis</subject><subject>Humans</subject><subject>mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>omega-3 fatty acids</subject><subject>patients</subject><subject>Peroxisome</subject><subject>Phenotype</subject><subject>phosphatidylethanolamines</subject><subject>Phosphatidylethanolamines - metabolism</subject><subject>Plasmalogen</subject><subject>Plasmalogens - metabolism</subject><subject>Severity of Illness Index</subject><issn>1388-1981</issn><issn>0006-3002</issn><issn>1879-2618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks9u1DAQxiMEoqXwBgj5yCXB4z9xckFCFbRIlbiUs-XEk41XThxi70p7QOIheEKepK62tPRCD5atmd984xl9RfEWaAUU6g_bquuMd0vFKIgKoKJUPitOoVFtyWponuc3b5oS2gZOilcxbikFybl8WZwwKWouVHta_LwME4aYTHSRhIEsY4j5ZF1nI_nz6ze5HpF43KN_SJvk7MFjGs0cvJncjCS5zZj8gRhrlhRJCqTP2Q1G4mbyiFy8iZPxYYNzfF28GIyP-ObuPiu-f_l8fX5ZXn27-Hr-6ars61qm0oKyg8FBKdvRbmAS-q4VqrOqVTzHpAJmRQ4YjpQr2UHXUzZYxmgG6MDPio9H3WXXTWh7nNNqvF5WN5n1oINx-nFmdqPehL0WnEOtRBZ4fyewhh87jElPLvbovZkx7KJmlFLOuajZkyg0jLdCSoCn0VpIlQeoZUbFEe3XEOOKw_3ngepbP-itPvpB3_pBA-jsh1z27t_B74v-GuBhM5jXv3e46tg7nHu0bsU-aRvc_zvcANvazQg</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Dorninger, Fabian</creator><creator>Brodde, Alexander</creator><creator>Braverman, Nancy E.</creator><creator>Moser, Ann B.</creator><creator>Just, Wilhelm W.</creator><creator>Forss-Petter, Sonja</creator><creator>Brügger, Britta</creator><creator>Berger, Johannes</creator><general>Elsevier B.V</general><general>Elsevier Pub. Co</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7S9</scope><scope>L.6</scope><scope>5PM</scope></search><sort><creationdate>20150201</creationdate><title>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</title><author>Dorninger, Fabian ; Brodde, Alexander ; Braverman, Nancy E. ; Moser, Ann B. ; Just, Wilhelm W. ; Forss-Petter, Sonja ; Brügger, Britta ; Berger, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c665t-d17dfaef77db0bf251cb947bd79737db5712d447ba3e0375b1bc02fd2209730f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acyltransferases - deficiency</topic><topic>Acyltransferases - genetics</topic><topic>Adaptation, Physiological</topic><topic>Alzheimer disease</topic><topic>Alzheimer's disease</topic><topic>Animals</topic><topic>Arachidonic acid</topic><topic>Arachidonic Acid - metabolism</topic><topic>biosynthesis</topic><topic>brain</topic><topic>cell membranes</topic><topic>Cells, Cultured</topic><topic>Chondrodysplasia Punctata, Rhizomelic - enzymology</topic><topic>Chondrodysplasia Punctata, Rhizomelic - genetics</topic><topic>Compensation</topic><topic>Disease Models, Animal</topic><topic>Docosahexaenoic acid</topic><topic>Docosahexaenoic Acids - metabolism</topic><topic>ethanolamine</topic><topic>fibroblasts</topic><topic>Fibroblasts - enzymology</topic><topic>Genetic Predisposition to Disease</topic><topic>Gray Matter - enzymology</topic><topic>Homeostasis</topic><topic>Humans</topic><topic>mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>omega-3 fatty acids</topic><topic>patients</topic><topic>Peroxisome</topic><topic>Phenotype</topic><topic>phosphatidylethanolamines</topic><topic>Phosphatidylethanolamines - metabolism</topic><topic>Plasmalogen</topic><topic>Plasmalogens - metabolism</topic><topic>Severity of Illness Index</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dorninger, Fabian</creatorcontrib><creatorcontrib>Brodde, Alexander</creatorcontrib><creatorcontrib>Braverman, Nancy E.</creatorcontrib><creatorcontrib>Moser, Ann B.</creatorcontrib><creatorcontrib>Just, Wilhelm W.</creatorcontrib><creatorcontrib>Forss-Petter, Sonja</creatorcontrib><creatorcontrib>Brügger, Britta</creatorcontrib><creatorcontrib>Berger, Johannes</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biochimica et biophysica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dorninger, Fabian</au><au>Brodde, Alexander</au><au>Braverman, Nancy E.</au><au>Moser, Ann B.</au><au>Just, Wilhelm W.</au><au>Forss-Petter, Sonja</au><au>Brügger, Britta</au><au>Berger, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens</atitle><jtitle>Biochimica et biophysica acta</jtitle><addtitle>Biochim Biophys Acta</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>1851</volume><issue>2</issue><spage>117</spage><epage>128</epage><pages>117-128</pages><issn>1388-1981</issn><issn>0006-3002</issn><eissn>1879-2618</eissn><abstract>Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential components of mammalian cellular membranes. Their importance is emphasized by the consequences of defects in plasmalogen biosynthesis, which in humans cause the fatal disease rhizomelic chondrodysplasia punctata (RCDP). In the present lipidomic study, we used fibroblasts derived from RCDP patients, as well as brain tissue from plasmalogen-deficient mice, to examine the compensatory mechanisms of lipid homeostasis in response to plasmalogen deficiency. Our results show that phosphatidylethanolamine (PE), a diacyl glycerophospholipid, which like ethanolamine plasmalogens carries the head group ethanolamine, is the main player in the adaptation to plasmalogen insufficiency. PE levels were tightly adjusted to the amount of ethanolamine plasmalogens so that their combined levels were kept constant. Similarly, the total amount of polyunsaturated fatty acids (PUFAs) in ethanolamine phospholipids was maintained upon plasmalogen deficiency. However, we found an increased incorporation of arachidonic acid at the expense of docosahexaenoic acid in the PE fraction of plasmalogen-deficient tissues. These data show that under conditions of reduced plasmalogen levels, the amount of total ethanolamine phospholipids is precisely maintained by a rise in PE. At the same time, a shift in the ratio between ω-6 and ω-3 PUFAs occurs, which might have unfavorable, long-term biological consequences. Therefore, our findings are not only of interest for RCDP but may have more widespread implications also for other disease conditions, as for example Alzheimer's disease, that have been associated with a decline in plasmalogens.
•PE accurately compensates for the lack of plasmalogens in vitro and in vivo.•PE levels decrease to adapt to excess of ethanolamine plasmalogens (PlsEtn).•Plasmalogen deficiency favors incorporation of arachidonic acid into PE.•Docosahexaenoic acid in ethanolamine phospholipids decreases upon PlsEtn depletion.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>25463479</pmid><doi>10.1016/j.bbalip.2014.11.005</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1388-1981 |
ispartof | Biochimica et biophysica acta, 2015-02, Vol.1851 (2), p.117-128 |
issn | 1388-1981 0006-3002 1879-2618 |
language | eng |
recordid | cdi_proquest_miscellaneous_2000333462 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Acyltransferases - deficiency Acyltransferases - genetics Adaptation, Physiological Alzheimer disease Alzheimer's disease Animals Arachidonic acid Arachidonic Acid - metabolism biosynthesis brain cell membranes Cells, Cultured Chondrodysplasia Punctata, Rhizomelic - enzymology Chondrodysplasia Punctata, Rhizomelic - genetics Compensation Disease Models, Animal Docosahexaenoic acid Docosahexaenoic Acids - metabolism ethanolamine fibroblasts Fibroblasts - enzymology Genetic Predisposition to Disease Gray Matter - enzymology Homeostasis Humans mice Mice, Inbred C57BL Mice, Knockout omega-3 fatty acids patients Peroxisome Phenotype phosphatidylethanolamines Phosphatidylethanolamines - metabolism Plasmalogen Plasmalogens - metabolism Severity of Illness Index |
title | Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T05%3A23%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homeostasis%20of%20phospholipids%20%E2%80%94%20The%20level%20of%20phosphatidylethanolamine%20tightly%20adapts%20to%20changes%20in%20ethanolamine%20plasmalogens&rft.jtitle=Biochimica%20et%20biophysica%20acta&rft.au=Dorninger,%20Fabian&rft.date=2015-02-01&rft.volume=1851&rft.issue=2&rft.spage=117&rft.epage=128&rft.pages=117-128&rft.issn=1388-1981&rft.eissn=1879-2618&rft_id=info:doi/10.1016/j.bbalip.2014.11.005&rft_dat=%3Cproquest_pubme%3E1645773065%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1645773065&rft_id=info:pmid/25463479&rft_els_id=S1388198114002443&rfr_iscdi=true |